The PROSPECT II study was published in the March 13th issue of The Lancet,
finding that IVUS+NIRS imaging can detect plaques at increased risk for future adverse cardiac outcomes.VIEW ARTICLE VIEW ARTICLE

Education

Webinar Sessions

New Avenues for the Detection and Treatment of Vulnerable Plaque Virtual Webinar

This virtual CME-accredited program is designed to help healthcare professionals stay current on new and emerging approaches in the detection, management and treatment of vulnerable plaque. View the webinar in three parts by clicking the links below.

Part 1: David Erlinge, MD Part 2: Lorenz Räber, MD Part 3: Gregg Stone, MD Part 4: Panel Discussion

Educational Sessions

EuroPCR e-Course

Featuring Dr. Giulio Guagliumi discussing the "Use of IVUS + NIRS imaging for decision making in Acute Coronary Syndrome.

Dr. Giulio Guagliumi, MD, FESC

Prospect II: A Prospective Natural History Study Using NIRS-IVUS Imaging in Patients With Acute Myocardial Infarction

Featuring David Erlinge, MD and Ron Waksman, MD.

View Webinar Details